Vijay Kumar
Stock Analyst at Evercore ISI Group
(3.37)
# 1,010
Out of 5,124 analysts
278
Total ratings
51.19%
Success rate
2.09%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Downgrades: In-Line | $79 → $78 | $74.90 | +4.14% | 17 | Jan 5, 2026 | |
| EXAS Exact Sciences | Downgrades: In-Line | $105 | $101.65 | +3.30% | 8 | Jan 5, 2026 | |
| BLCO Bausch + Lomb | Downgrades: In-Line | $18 | $17.13 | +5.08% | 12 | Jan 5, 2026 | |
| AVTR Avantor | Downgrades: In-Line | $14 → $12 | $12.18 | -1.48% | 13 | Jan 5, 2026 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Outperform | $94 → $120 | $94.13 | +27.49% | 15 | Jan 5, 2026 | |
| IRTC iRhythm Technologies | Upgrades: Outperform | $194 → $210 | $185.17 | +13.41% | 3 | Jan 5, 2026 | |
| AZTA Azenta | Upgrades: Outperform | $34 → $50 | $36.49 | +37.02% | 9 | Jan 5, 2026 | |
| A Agilent Technologies | Upgrades: Outperform | $155 → $160 | $146.21 | +9.43% | 8 | Jan 5, 2026 | |
| SYK Stryker | Maintains: Outperform | $410 → $405 | $361.09 | +12.16% | 13 | Oct 31, 2025 | |
| ILMN Illumina | Maintains: Outperform | $132 → $142 | $144.16 | -1.50% | 9 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $92 | $86.14 | +6.80% | 15 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $92 | $86.59 | +6.25% | 5 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $155 → $168 | $205.96 | -18.43% | 8 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $144 → $142 | $128.39 | +10.60% | 17 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $42 | $36.23 | +15.93% | 6 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $525 → $590 | $618.77 | -4.65% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $108 → $106 | $104.36 | +1.57% | 3 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $285 | $315.72 | -9.73% | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,275 → $1,400 | $1,482.97 | -5.59% | 12 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $535 → $450 | $590.56 | -23.80% | 14 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $226 → $245 | $235.61 | +3.99% | 4 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $110 | $96.98 | +13.43% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $31 | $20.40 | +52.00% | 8 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $49 → $54 | $56.03 | -3.62% | 7 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $40 | $27.68 | +44.51% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $103 → $106 | $100.03 | +5.97% | 5 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $46 | $27.51 | +67.21% | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $3 | $2.45 | +22.45% | 6 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $14.09 | +112.92% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $399.81 | -11.21% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $86.59 | +84.78% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $203.55 | +42.47% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.02 | +586.27% | 1 | May 31, 2022 |
Hologic
Jan 5, 2026
Downgrades: In-Line
Price Target: $79 → $78
Current: $74.90
Upside: +4.14%
Exact Sciences
Jan 5, 2026
Downgrades: In-Line
Price Target: $105
Current: $101.65
Upside: +3.30%
Bausch + Lomb
Jan 5, 2026
Downgrades: In-Line
Price Target: $18
Current: $17.13
Upside: +5.08%
Avantor
Jan 5, 2026
Downgrades: In-Line
Price Target: $14 → $12
Current: $12.18
Upside: -1.48%
Zimmer Biomet Holdings
Jan 5, 2026
Upgrades: Outperform
Price Target: $94 → $120
Current: $94.13
Upside: +27.49%
iRhythm Technologies
Jan 5, 2026
Upgrades: Outperform
Price Target: $194 → $210
Current: $185.17
Upside: +13.41%
Azenta
Jan 5, 2026
Upgrades: Outperform
Price Target: $34 → $50
Current: $36.49
Upside: +37.02%
Agilent Technologies
Jan 5, 2026
Upgrades: Outperform
Price Target: $155 → $160
Current: $146.21
Upside: +9.43%
Stryker
Oct 31, 2025
Maintains: Outperform
Price Target: $410 → $405
Current: $361.09
Upside: +12.16%
Illumina
Oct 31, 2025
Maintains: Outperform
Price Target: $132 → $142
Current: $144.16
Upside: -1.50%
Oct 31, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $86.14
Upside: +6.80%
Oct 30, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $86.59
Upside: +6.25%
Oct 16, 2025
Maintains: Outperform
Price Target: $155 → $168
Current: $205.96
Upside: -18.43%
Oct 16, 2025
Maintains: Outperform
Price Target: $144 → $142
Current: $128.39
Upside: +10.60%
Oct 7, 2025
Maintains: Outperform
Price Target: $46 → $42
Current: $36.23
Upside: +15.93%
Oct 7, 2025
Maintains: Outperform
Price Target: $525 → $590
Current: $618.77
Upside: -4.65%
Oct 7, 2025
Maintains: Outperform
Price Target: $108 → $106
Current: $104.36
Upside: +1.57%
Oct 7, 2025
Maintains: Outperform
Price Target: $300 → $285
Current: $315.72
Upside: -9.73%
Oct 7, 2025
Maintains: Outperform
Price Target: $1,275 → $1,400
Current: $1,482.97
Upside: -5.59%
Oct 7, 2025
Maintains: In-Line
Price Target: $535 → $450
Current: $590.56
Upside: -23.80%
Oct 7, 2025
Maintains: Outperform
Price Target: $226 → $245
Current: $235.61
Upside: +3.99%
Oct 7, 2025
Maintains: Outperform
Price Target: $115 → $110
Current: $96.98
Upside: +13.43%
Oct 7, 2025
Maintains: Outperform
Price Target: $33 → $31
Current: $20.40
Upside: +52.00%
Sep 30, 2025
Maintains: In-Line
Price Target: $49 → $54
Current: $56.03
Upside: -3.62%
Aug 13, 2025
Maintains: Outperform
Price Target: $33 → $40
Current: $27.68
Upside: +44.51%
Jul 8, 2025
Maintains: Outperform
Price Target: $103 → $106
Current: $100.03
Upside: +5.97%
Jul 8, 2025
Maintains: Outperform
Price Target: $48 → $46
Current: $27.51
Upside: +67.21%
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $2.45
Upside: +22.45%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $14.09
Upside: +112.92%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $399.81
Upside: -11.21%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $86.59
Upside: +84.78%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $203.55
Upside: +42.47%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $1.02
Upside: +586.27%